Publications by authors named "Cameron Bader"

Claim this Profile
S
Synergistic venetoclax and aCD3 therapy for control of alloreactive response in hematopoietic stem cell transplantation.
Bettina P Iliopoulou, Shiva Pathak, Blake Mosher, Levon Witherspoon, Alexandra Wells, Cameron S Bader

Am J Transplant· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined nonmyeloablative total lymphoid irradiation and low-dose total body irradiation enhances donor chimerism and leads to islet allograft acceptance.
Shiva Pathak, Bettina P Iliopoulou, Blake Mosher, Alexandra Wells, Levon Witherspoon, Cameron S Bader

Am J Transplant· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory T cell approaches for graft-versus-host disease prevention.
Cameron S Bader, Everett H Meyer, Robert S Negrin

Curr Opin Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor regulatory T-cell therapy to prevent graft-versus-host disease.
Everett H Meyer, Anna Pavlova, Alejandro Villar-Prados, Cameron Bader, Bryan Xie

Blood· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minnelide suppresses GVHD and enhances survival while maintaining GVT responses.
Sabrina N Copsel, Vanessa T Garrido, Henry Barreras, Cameron S Bader, Brent Pfeiffer

JCI Insight· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-center randomized trial of T-reg graft alone vs T-reg graft plus tacrolimus for the prevention of acute GVHD.
Cameron S Bader, Anna Pavlova, Robert Lowsky, Lori S Muffly, Parveen Shiraz

Blood Adv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory T Cell Amelioration of Graft-versus-Host Disease following Allogeneic/Xenogeneic Hematopoietic Stem Cell Transplantation Using Mobilized Mouse and Human Peripheral Blood Donors.
Henry Barreras, Sabrina N Copsel, Cameron S Bader, Ying Ding, Dietlinde Wolf

Transplant Cell Ther· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoregulatory effects of RGMb in gut inflammation.
Magdiel Pérez-Cruz, Bettina P Iliopoulou, Katie Hsu, Hsin-Hsu Wu, Tom Erkers, Cameron S Bader

Front Immunol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Post-transplant Cyclophosphamide Treatment to Build a Tolerance Platform to Prevent Liquid and Solid Organ Allograft Rejection.
Casey O Lightbourn, Dietlinde Wolf, Sabrina N Copsel, Ying Wang, Brent J Pfeiffer, Cameron S Bader

Front Immunol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STING and transplantation: can targeting this pathway improve outcomes?
Cameron S Bader, Lei Jin, Robert B Levy

Blood· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STING differentially regulates experimental GVHD mediated by CD8 versus CD4 T cell subsets.
Cameron S Bader, Henry Barreras, Casey O Lightbourn, Sabrina N Copsel, Dietlinde Wolf

Sci Transl Med· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT.
Sabrina N Copsel, Casey O Lightbourn, Henry Barreras, Ines Lohse, Dietlinde Wolf, Cameron S Bader

Front Immunol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Superior immune reconstitution using Treg-expanded donor cells versus PTCy treatment in preclinical HSCT models.
Dietlinde Wolf, Cameron S Bader, Henry Barreras, Sabrina Copsel, Brent J Pfeiffer

JCI Insight· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Very Low Numbers of CD4 FoxP3 Tregs Expanded in Donors via TL1A-Ig and Low-Dose IL-2 Exhibit a Distinct Activation/Functional Profile and Suppress GVHD in a Preclinical Model.
Sabrina Copsel, Dietlinde Wolf, Brandon Kale, Henry Barreras, Casey O Lightbourn, Cameron S Bader

Biol Blood Marrow Transplant· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Marked in Vivo Donor Regulatory T Cell Expansion via Interleukin-2 and TL1A-Ig Stimulation Ameliorates Graft-versus-Host Disease but Preserves Graft-versus-Leukemia in Recipients after Hematopoietic Stem Cell Transplantation.
Dietlinde Wolf, Henry Barreras, Cameron S Bader, Sabrina Copsel, Casey O Lightbourn

Biol Blood Marrow Transplant· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis